FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2743295977> ?p ?o ?g. }

• W2743295977 endingPage "17" @default.
• W2743295977 startingPage "11" @default.
• W2743295977 abstract "Abstract Introduction The optimal duration of osteoporosis treatment is controversial. As opposed to bisphosphonates, denosumab does not incorporate into bone matrix and bone turnover is not suppressed after its cessation. Recent reports imply that denosumab discontinuation may lead to an increased risk of multiple vertebral fractures. Methods The European Calcified Tissue Society (ECTS) formed a working group to perform a systematic review of existing literature on the effects of stopping denosumab and provide advice on management. Results Data from phase 2 and 3 clinical trials underscore a rapid decrease of bone mineral density (BMD) and a steep increase in bone turnover markers (BTMs) after discontinuation of denosumab. Clinical case series report multiple vertebral fractures after discontinuation of denosumab and a renewed analysis of FREEDOM and FREEDOM Extension Trial suggests, albeit does not prove, that the risk of multiple vertebral fractures may be increased when denosumab is stopped due to a rebound increase in bone resorption. Conclusion There appears to be an increased risk of multiple vertebral fractures after discontinuation of denosumab although strong evidence for such an effect and for measures to prevent the occurring bone loss is lacking. Clinicians and patients should be aware of this potential risk. Based on available data, a re-evaluation should be performed after 5 years of denosumab treatment. Patients considered at high fracture risk should either continue denosumab therapy for up to 10 years or be switched to an alternative treatment. For patients at low risk, a decision to discontinue denosumab could be made after 5 years, but bisphosphonate therapy should be considered to reduce or prevent the rebound increase in bone turnover. However, since the optimal bisphosphonate regimen post-denosumab is currently unknown continuation of denosumab can also be considered until results from ongoing trials become available. Based on current data, denosumab should not be stopped without considering alternative treatment in order to prevent rapid BMD loss and a potential rebound in vertebral fracture risk." @default.
• W2743295977 created "2017-08-17" @default.
• W2743295977 creator A5001194934 @default.
• W2743295977 creator A5002215271 @default.
• W2743295977 creator A5036667571 @default.
• W2743295977 creator A5043082129 @default.
• W2743295977 creator A5053558726 @default.
• W2743295977 creator A5064307236 @default.
• W2743295977 creator A5066827451 @default.
• W2743295977 creator A5067638427 @default.
• W2743295977 creator A5067726769 @default.
• W2743295977 creator A5067955208 @default.
• W2743295977 date "2017-12-01" @default.
• W2743295977 modified "2023-10-18" @default.
• W2743295977 title "Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS" @default.
• W2743295977 cites W13052883 @default.
• W2743295977 cites W1777836280 @default.
• W2743295977 cites W1911703092 @default.
• W2743295977 cites W1974976392 @default.
• W2743295977 cites W1986913997 @default.
• W2743295977 cites W1990771263 @default.
• W2743295977 cites W2021748249 @default.
• W2743295977 cites W2028209514 @default.
• W2743295977 cites W2029585349 @default.
• W2743295977 cites W2033248671 @default.
• W2743295977 cites W2039839937 @default.
• W2743295977 cites W2049124722 @default.
• W2743295977 cites W2084865918 @default.
• W2743295977 cites W2090969611 @default.
• W2743295977 cites W2106406207 @default.
• W2743295977 cites W2128076211 @default.
• W2743295977 cites W2134910437 @default.
• W2743295977 cites W2160005424 @default.
• W2743295977 cites W2163058169 @default.
• W2743295977 cites W2184568367 @default.
• W2743295977 cites W2220606005 @default.
• W2743295977 cites W2232765876 @default.
• W2743295977 cites W2269624093 @default.
• W2743295977 cites W2292160233 @default.
• W2743295977 cites W2336685537 @default.
• W2743295977 cites W2467654445 @default.
• W2743295977 cites W2531903877 @default.
• W2743295977 cites W2553677537 @default.
• W2743295977 cites W2570418334 @default.
• W2743295977 cites W2584827529 @default.
• W2743295977 cites W2592154370 @default.
• W2743295977 cites W2592545064 @default.
• W2743295977 cites W2594420699 @default.
• W2743295977 cites W2607192853 @default.
• W2743295977 cites W2612475646 @default.
• W2743295977 cites W2619448414 @default.
• W2743295977 cites W2620350575 @default.
• W2743295977 cites W2621525643 @default.
• W2743295977 doi "https://doi.org/10.1016/j.bone.2017.08.003" @default.
• W2743295977 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28789921" @default.
• W2743295977 hasPublicationYear "2017" @default.
• W2743295977 type Work @default.
• W2743295977 sameAs 2743295977 @default.
• W2743295977 citedByCount "347" @default.
• W2743295977 countsByYear W27432959772017 @default.
• W2743295977 countsByYear W27432959772018 @default.
• W2743295977 countsByYear W27432959772019 @default.
• W2743295977 countsByYear W27432959772020 @default.
• W2743295977 countsByYear W27432959772021 @default.
• W2743295977 countsByYear W27432959772022 @default.
• W2743295977 countsByYear W27432959772023 @default.
• W2743295977 crossrefType "journal-article" @default.
• W2743295977 hasAuthorship W2743295977A5001194934 @default.
• W2743295977 hasAuthorship W2743295977A5002215271 @default.
• W2743295977 hasAuthorship W2743295977A5036667571 @default.
• W2743295977 hasAuthorship W2743295977A5043082129 @default.
• W2743295977 hasAuthorship W2743295977A5053558726 @default.
• W2743295977 hasAuthorship W2743295977A5064307236 @default.
• W2743295977 hasAuthorship W2743295977A5066827451 @default.
• W2743295977 hasAuthorship W2743295977A5067638427 @default.
• W2743295977 hasAuthorship W2743295977A5067726769 @default.
• W2743295977 hasAuthorship W2743295977A5067955208 @default.
• W2743295977 hasConcept C126322002 @default.
• W2743295977 hasConcept C17744445 @default.
• W2743295977 hasConcept C177713679 @default.
• W2743295977 hasConcept C199539241 @default.
• W2743295977 hasConcept C2776286101 @default.
• W2743295977 hasConcept C2776541429 @default.
• W2743295977 hasConcept C2777026412 @default.
• W2743295977 hasConcept C2778715236 @default.
• W2743295977 hasConcept C2994133304 @default.
• W2743295977 hasConcept C512399662 @default.
• W2743295977 hasConcept C71924100 @default.
• W2743295977 hasConceptScore W2743295977C126322002 @default.
• W2743295977 hasConceptScore W2743295977C17744445 @default.
• W2743295977 hasConceptScore W2743295977C177713679 @default.
• W2743295977 hasConceptScore W2743295977C199539241 @default.
• W2743295977 hasConceptScore W2743295977C2776286101 @default.
• W2743295977 hasConceptScore W2743295977C2776541429 @default.
• W2743295977 hasConceptScore W2743295977C2777026412 @default.
• W2743295977 hasConceptScore W2743295977C2778715236 @default.
• W2743295977 hasConceptScore W2743295977C2994133304 @default.
• W2743295977 hasConceptScore W2743295977C512399662 @default.

• next